Global Cholera Vaccines Market, By Product Type, By Vaccine Type, By Patient Type, By Distribution Channel, By Geography

Description

The global cholera vaccines market was valued US$ 82.5 Mn in 2023 and is expected to reach US$ 204.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 12% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 82.5 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	12.00%	2030/2031 Value Projection:	US$ 204.6 Mn

Figure 1. Global Cholera Vaccines Market Share (%), By Region, 2023

Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inadequate hygiene, such as Africa, Southeast Asia, and Haiti. The World Health Organization (WHO) and the UN Children's Fund (UNICEF) have warned that cholera is making a devastating comeback, particularly targeting vulnerable communities. The risk of a cholera epidemic is highest when poverty, war, or natural disasters force people to live in crowded conditions without adequate sanitation. Cholera is a disease of poverty, affecting people with inadequate access to safe water and basic sanitation. The infection is not likely to spread directly from one person to another; therefore, casual contact with an infected person is not a significant risk factor for becoming ill. In terms of prevention, a multifaceted approach is key to controlling cholera and reducing deaths. This includes ensuring access to safe water, adequate sanitation, and hygiene, as well as vaccination in high-risk areas.

Market Dynamics:

Key drivers favoring the growth of global cholera vaccines market include the rising burden of cholera disease globally, growing focus on preventing cholera outbreaks, and the development of novel oral vaccines with a longer duration of protection. However, factors such as insufficient access to vaccines in low-income regions, and a lack of awareness about immunization in certain communities continue to restrain the market potential to a certain extent. On the optimistic side, increasing investments in the research of vaccines providing cross-protection against multiple serotypes open up new avenues. Partnerships between makers and international organizations for improving availability in endemic areas also present attractive opportunities over the next few years.

Key features of the study:

This report provides in-depth analysis of the global cholera vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cholera vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include Sanofi, Biovac.co.za., EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital), PaxVax, Inc., Astellas Pharma Inc., and EUBIOLOGICS CO., LTD.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cholera vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cholera vaccines market

Detailed Segmentation:

Global Cholera Vaccines Market, By Product Type
- Vaxchora
- Dukoral
- ShanChol
- Euvichol-Plus/Euvichol
- Others (Late Phase Vaccines, etc.)
Global Cholera Vaccines Market, By Vaccine Type
- Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
- Killed Whole-cell Only Vaccines
- Live Attenuated Oral Cholera Vaccine
Global Cholera Vaccines Market, By Patient Type
- Pediatric
- Adults
Global Cholera Vaccines Market, By Distribution Channel
- Public
- Private
Global Cholera Vaccines Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top Companies in the Global Cholera Vaccines Market:
- Sanofi
- Biovac.co.za.
- EMERGENT
- Celldex Therapeutics
- Valneva SE
- Hilleman Laboratories
- Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
- PaxVax, Inc.
- Astellas Pharma Inc.
- EUBIOLOGICS CO., LTD.

Product Code: CMI6646

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Vaccine Type
- Market Snippet, By Patient Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing Vaccination Campaigns
- Supply Shortage of Cholera Vaccine
- Increasing Educational Training Programmes
Key Highlights
Regulatory Scenario
Market Trends
Pipeline Analysis
Product Launch/Approval
PEST Analysis
PORTER's Analysis
Epidemiology
Treatment Algorithm (Patient Journey)
Treatment Option Analysis
New Investments by Major Market Players
Pricing Analysis
Disease Awareness Programs
Treatment Safety and Efficacy Analysis
Mergers, Acquisitions, and Collaborations

4. Global Cholera Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Cholera Vaccines Market, By Product Type, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Vaxchora
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Dukoral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
ShanChol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Euvichol-Plus/Euvichol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Others (Late Phase Vaccines, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Cholera Vaccines Market, By Vaccine Type, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Killed Whole-cell Only Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Live Attenuated Oral Cholera Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Cholera Vaccines Market, By Patient Type, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Cholera Vaccines Market, By Distribution Channel, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 201s9-2031,(US$ Mn)

9. Global Cholera Vaccines Market, By Region, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 -2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profile
- Sanofi
- Biovac.co.za.
- EMERGENT
- Celldex Therapeutics
- Valneva SE
- Hilleman Laboratories
- Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
- PaxVax, Inc.
- Astellas Pharma Inc.
- EUBIOLOGICS CO., LTD.
Analyst Views

11. Section

References
Research Methodology
About us